Back to search results

Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Colorado, Aurora, Colorado, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Sana Karam, M.D., Ph.D.) · sanadkaram@wustl.edu · 314-273-3240
    Contact: Principal Investigator (Sana Karam, M.D., Ph.D.)
    Roheena Panni, M.D. (Sub-investigator)
    Kian-Huat Lim, M.D. (Sub-investigator)
    Michael Waters, M.D., Ph.D. (Sub-investigator)
    Nikolaos Andreatos, M.D. (Sub-investigator)
    Olivia Aranha, M.D., Ph.D. (Sub-investigator)
    Patrick Grierson, M.D., Ph.D. (Sub-investigator)
    Joseph Harms, Ph.D., DABR (Sub-investigator)
    Ramon Jin, M.D., Ph.D. (Sub-investigator)
    Moh'd Khushman, M.D. (Sub-investigator)
    Chunjie Li, M.D., Ph.D. (Sub-investigator)
    Trang Nguyen, M.D. (Sub-investigator)
    Caron Rigden, M.D. (Sub-investigator)
    Dominic Sanford, M.D. (Sub-investigator)
    Mark Sundermeyer, M.D. (Sub-investigator)
    Rama Suresh, M.D. (Sub-investigator)
    Ben Tan, M.D. (Sub-investigator)
    Junxiao Hu, Ph.D. (Sub-investigator)
Study leads

  • Sana Karam, M.D., Ph.D.

    Principal Investigator

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)